Key facts
- This page summarizes Christian Pittard's Form 4 filing for abrdn Life Sciences Investors (HQL).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 18 Dec 2025, 11:16.
Christian Pittard - 16 Dec 2025 Form 4 Insider Report for abrdn Life Sciences Investors (HQL)
- Reporting relationship
- Director
- Issuer ticker
- HQL
- Reported as of
- 16 Dec 2025
- Net transaction value
- +$133,755
- SEC form
- 4
- Accepted by SEC
- 18 Dec 2025, 11:16:37 UTC
- Prior SEC filing
- 06 Nov 2023
- Next SEC filing
- 17 Jun 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Robert Stieger, by POA from Reporting Person
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Christian Pittard filed Form 4 for abrdn Life Sciences Investors (HQL) on 18 Dec 2025.
Change
- Previous filing in this sequence was filed on 06 Nov 2023.
- Current net transaction value: +$133,755.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001340575
Primary reporting owner
Pittard Christian
- Relationship
- Director
- Address
- C/O ABRDN, 1900 MARKET STREET, SUITE 200, PHILADELPHIA
- Signature
- /s/ Robert Stieger, by POA from Reporting Person
- Signature date
- 18 Dec 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
HQL
transaction
Common Stock
Purchase
- Transaction value
- $133,755
- Shares
- +7,923
- Change %
- Price
- $16.88
- Shares after
- 7,923
- Date
- 16 Dec 2025
- Ownership
- Direct
* marks a reported price that did not pass the local price check.